M. Binaschi et al., IRREVERSIBLE AND REVERSIBLE TOPOISOMERASE-II DNA CLEAVAGE STIMULATED BY CLEROCIDIN - SEQUENCE SPECIFICITY AND STRUCTURAL DRUG DETERMINANTS, Cancer research, 57(9), 1997, pp. 1710-1716
In contrast to other topoisomerase II poisons, the microbial terpenoid
clerocidin was shown to stimulate irreversible topoisomerase II-media
ted DNA cleavage. To establish the structural determinants for drug ac
tivity, in this study we have investigated intensity patterns and sequ
ence specificity of clerocidin-stimulated DNA cleavage using 5'-end P-
32-labeled DNA fragments. At a majority of the sites, clerocidin-stimu
lated cleavage did not revert upon NaCl addition; nevertheless, at som
e sites, cleavage completely reverted. Statistical analyses showed tha
t drug-preferred bases were different in the two cases: guanine and cy
tosine were highly preferred at position -1 at irreversible and revers
ible sites, respectively. These results demonstrated that cleavage irr
eversibility was site selective and required a guanine at the 3' end o
f the cut. Further experiments revealed that some irreversible sites s
howed an abnormal electrophoretic mobility in sequencing gels with res
pect to cleaved bands generated by 4-(9-acridinylamino)methanesulfon-m
-anisidide, suggesting a chemical alteration of the DNA strand. Intere
stingly, the ability to stimulate irreversible cleavage progressively
decreased over time when clerocidin was stored in ethanol. Under these
conditions, nuclear magnetic resonance measurements demonstrated that
the drug underwent structural modifications that involved the C-12-C-
15 side chain. Thus, the results indicate that a specific moiety of cl
erocidin may react with the DNA (guanine at -1) in the ternary complex
, resulting in cleavage irreversibility and in altered DNA mobility in
sequencing gels.